Loading resource…

authorities
HIV infection in pregnant women poses significant risks, but effective treatment with HAART can improve outcomes. The document discusses the importance of antenatal HIV screening and the role of zidovudine in preventing mother-to-child transmission. It also addresses the mode of delivery for HIV-positive women and the necessity of registering these patients with the Anti-retroviral Pregnancy Registry. Evidence levels for various recommendations are provided, highlighting the need for clinical judgment in the absence of randomized trials.
No account needed